share_log

Summit Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 30, 2021

Summit Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 30, 2021

健峰醫療收購股份有限公司宣佈自 2021 年 7 月 30 日起獨立交易其 A 類普通股及認股權證
businesswire ·  2021/07/27 20:00

HONG KONG--(BUSINESS WIRE)--Summit Healthcare Acquisition Corp. (the “Company”) announced today that, commencing July 30, 2021, holders of the units sold in the Company’s initial public offering of 20,000,000 units, completed on June 11, 2021, may elect to separately trade the shares of Class A ordinary shares and warrants included in the units. Those units not separated will continue to trade on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “SMIHU,” and the shares of Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols “SMIH” and “SMIHW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants.

香港--(商業資訊)-峰峰醫療收購股份有限公司(「本公司」)今天宣佈,自 2021 年 7 月 30 日起,本公司於 2021 年 6 月 11 日完成之首次公開發行 20,000,000 單位中出售之單位持有人可選擇另行買賣該單位所包含之 A 類普通股及認股權證之股份。那些未分離的單位將繼續以「SMIHU」代號在納斯達克資本市場(「納斯達克」)進行交易,而 A 類普通股和認股權證的股份將分別以「SMIH」和「SMIHW」代號在納斯達克交易。單位分離後不會發出任何分數認股權證,只有整個認股權證才可買賣。單位持有人需要讓其經紀人聯絡本公司的轉讓代理大陸股票轉讓信託公司,以便將單位分為 A 類普通股和認股權證。

The offering was made only by means of a prospectus, copies of which may be obtained from BofA Securities, Inc., NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department or by emailing dg.prospectus_requests@bofa.com.

發行僅通過招股說明書提出,其副本可以從美銀證券有限公司獲得,NC1-004-03-43,北學院街 200 號,夏洛特北卡羅來納州北卡羅來納州 28255-0001,收件人:招股章程部或通過電子郵件發送 dg.prospectus_requests@bofa.com。

BofA Securities, Inc. acted as sole book-running manager of the offering. A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on June 8, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

美銀證券股份有限公司擔任該發售的獨家圖書經理。美國證券交易委員會(「美國證券交易委員會」)於 2021 年 6 月 8 日宣布有關證券的註冊聲明生效。本新聞稿不構成要約出售或徵求購買要約,也不得在任何該等國家或司法管轄區根據任何該等州或司法管轄區的證券法進行註冊或資格之前,該等要約、招攬或出售將屬違法的任何國家或司法管轄區的任何國家或司法管轄區的任何國家或司法管轄區的任何國家或司法管轄區的任何司法

About Summit Healthcare Acquisition Corp.

關於峰頂醫療收購股份有

Summit Healthcare Acquisition Corp. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Although the Company’s efforts to identify a prospective target business will not be limited to a particular geographic region or industry, it intends to focus on potential acquisition targets in the healthcare industry with a strong China nexus.

Summit Healthcare 收購股份有限公司的成立目的是實現合併,股份交換,資產收購,股份購買,重組或與一個或多個企業的類似業務合併。儘管公司為確定潛在目標業務所做的努力不僅限於特定的地理區域或行業,但該公司打算專注於具有強大中國關係的醫療保健行業的潛在收購目標。

Cautionary Note Concerning Forward-Looking Statements

有關前瞻性陳述的注意事項

This press release contains statements that constitute "forward-looking statements," including with respect to the Company’s search for an initial business combination. No assurance can be given that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the initial public offering filed with the SEC. Copies are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

本新聞稿包含構成「前瞻性陳述」的聲明,包括關於公司搜索初始業務組合的聲明。不能保證本公司最終將完成一項業務合併交易。前瞻性聲明受多項條件約束,其中許多條件均無法控制,包括本公司註冊聲明書中「風險因素」一節所載的內容,以及向 SEC 提交的首次公開發行的招股章程。副本可在美國證券交易委員會的網站上取得,網址為 www.sec.gov。除非法律要求,否則本公司無義務在本發布日期之後更新這些聲明以進行修改或更改。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論